GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elanix Biotechnologies AG (FRA:ELN) » Definitions » 5-Year Dividend Growth Rate

Elanix Biotechnologies AG (FRA:ELN) 5-Year Dividend Growth Rate : 0.00% (As of Dec. 2018)


View and export this data going back to . Start your Free Trial

What is Elanix Biotechnologies AG 5-Year Dividend Growth Rate?

Elanix Biotechnologies AG's Dividends per Share for the six months ended in Dec. 2018 was €0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Elanix Biotechnologies AG's Dividend Payout Ratio for the six months ended in Dec. 2018 was 0.00. As of today, Elanix Biotechnologies AG's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Elanix Biotechnologies AG's 5-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Elanix Biotechnologies AG's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elanix Biotechnologies AG's 5-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elanix Biotechnologies AG's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Elanix Biotechnologies AG's 5-Year Dividend Growth Rate falls into.



Elanix Biotechnologies AG 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Elanix Biotechnologies AG  (FRA:ELN) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Elanix Biotechnologies AG's Dividend Payout Ratio for the quarter that ended in Dec. 2018 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2018 )/ EPS without NRI (Q: Dec. 2018 )
=0/ -12.141
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elanix Biotechnologies AG 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of Elanix Biotechnologies AG's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Elanix Biotechnologies AG (FRA:ELN) Business Description

Traded in Other Exchanges
N/A
Address
Street-4, Georg-Glock, c/o HEUKING KÜHN LÜER WOJTEK, Dusseldorf, NW, DEU, 40474
Elanix Biotechnologies AG is a tissue regeneration company. It develops and commercializes products for acute wound care, dermatological and gynecological applications as well as providing cell technology services. The company's operating segment include Regenerative Medicine and Cosmetic ointments. It generates maximum revenue from the Cosmetic ointments segment. Geographically, it derives a majority of revenue from Switzerland and also has a presence in the EU, and Taiwan.

Elanix Biotechnologies AG (FRA:ELN) Headlines

No Headlines